Michael Buschle
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Virus-based gene therapy research, RNA Interference and Gene Delivery, CAR-T cell therapy research, vaccines and immunoinformatics approaches
Most-Cited Works
- → Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients(1993)425 cited
- → Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin(1989)307 cited
- → Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.(1993)249 cited
- → Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus(2002)216 cited
- Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus.(1994)
- → IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses(2006)157 cited
- → Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41(2008)153 cited
- → Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects(2006)139 cited
- → Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein(1993)130 cited
- → Immunotherapy of Metastatic Malignant Melanoma by a Vaccine Consisting of Autologous Interleukin 2-Transfected Cancer Cells: Outcome of a Phase I Study(1999)127 cited